Unique Features of Melasma
Melasma can be unique in each person
Melasma is a skin condition marked by darkly discolored patches that appear most commonly on the face. It can appear as a small spot or take up large areas. Regardless of how small or large, melasma is emotionally distressing because it changes facial appearance. Melasma is common among many different ethnicities.[1,2] There are many therapies directed toward treating melasma including hydroquinone, retinol, laser treatments and the use of emerging botanical treatments.
Good questions to ask are:
- Is all melasma created equal?
- Will your melasma improve with the same treatments that helped a friend?
The short answer is that not all melasma is created equal, and what helped a friend may not help you. It depends on what is triggering the discoloration. Here are a few nuances that you should consider.
Is My Melasma Really Melasma, or Is It Something Else?
There are many conditions within dermatology that can look similar to melasma to an untrained eye. Some examples include birthmarks, sunspots (lentigines), and even melanoma skin cancer. It is very important that persistent dark spots on the face be evaluated by a healthcare provider to rule out skin cancer before thinking about treatments to get rid of the pigment.
What Can Trigger Melasma?
Several factors are associated with melasma.
Hormones play an important role in melasma. Studies show that female sexual hormones, such as estrogen and progestins, are important in the development of melasma. Melasma is more common in women and is common in pregnancy.[1,2] Further support for the hormonal triggers for melasma is that the use of oral contraceptive pills is associated with its development.[3,4] Changes in the levels of the thyroid hormone have also been associated with melasma.
Ultraviolet light can stimulate the skin to produce more pigment, leading to melasma.[1,2,6] Both ultraviolet light type A and type B from the sun are involved in triggering the formation of melasma.
Family history (i.e. the occurrence of melasma in other family members) plays an important role.[7,8] Studies have estimated that family history was reported in at least 10% and even up to 48% of those with melasma.[8,9]
Is My Melasma Occurring at the Skin Surface?
Yes, but melasma can be found at several different skin depths and this can affect the success of treatments. It may be helpful to think of melasma as occurring in two separate depths of skin, although many people will have an overlap between the two forms:
- Epidermal melasma: skin pigment is overproduced in the more superficial layer of the skin known as the epidermis. Epidermal melasma is more likely to improve with treatment.
- Dermal melasma: pigment is found in the deeper layers of the skin known as the dermis. This type of melasma is harder to treat because treatments may have a harder time penetrating to greater depths in the skin where they would be active against melasma.
Melasma can be psychologically distressing and is challenging to treat. It is important to understand that several different factors affect the development of melasma. Understanding the unique causes and variations in each individual is important before delving into treatments.
1. Handel AC, Miot LD, Miot HA. Melasma: a clinical and epidemiological review. An Bras Dermatol.2014;89(5):771-782; PMID: 25184917.
2. Cestari T, Arellano I, Hexsel D, et al. Melasma in Latin America: options for therapy and treatment algorithm. J Eur Acad Dermatol Venereol.2009;23(7):760-772; PMID: 19646135.
3. Locci-Molina N, Wang A, Kroumpouzos G. Melasma Improving Spontaneously upon Switching from a Combined Oral Contraceptive to a Hormone-releasing Intrauterine Device: A Report of Four Cases. Acta Derm Venereol.2015;95(5):624-625; PMID: 25394784.
4. Resnik S. Melasma induced by oral contraceptive drugs. JAMA.1967;199(9):601-605; PMID: 6071249.
5. Lutfi RJ, Fridmanis M, Misiunas AL, et al. Association of melasma with thyroid autoimmunity and other thyroidal abnormalities and their relationship to the origin of the melasma. J Clin Endocrinol Metab.1985;61(1):28-31; PMID: 3923030.
6. Wu IB, Lambert C, Lotti TM, et al. Melasma. G Ital Dermatol Venereol.2012;147(4):413-418; PMID: 23007216.
7. Tamega Ade A, Miot LD, Bonfietti C, et al. Clinical patterns and epidemiological characteristics of facial melasma in Brazilian women. J Eur Acad Dermatol Venereol.2013;27(2):151-156; PMID: 22212073.
8. Ortonne JP, Arellano I, Berneburg M, et al. A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma. J Eur Acad Dermatol Venereol.2009;23(11):1254-1262; PMID: 19486232.
9. Goh CL, Dlova CN. A retrospective study on the clinical presentation and treatment outcome of melasma in a tertiary dermatological referral centre in Singapore. Singapore Med J.1999;40(7):455-458; PMID: 10560271.
10. Fisk WA, Agbai O, Lev-Tov HA, et al. The use of botanically derived agents for hyperpigmentation: a systematic review. J Am Acad Dermatol.2014;70(2):352-365; PMID: 24280646.
11. Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol.2010;3(7):20-31; PMID: 20725554.